COPD and asthma: Diagnostic accuracy requires spirometry

,; ,

Applied Evidence

COPD and asthma: Diagnostic accuracy requires spirometry

J Fam Pract. 2019 March;68(2):76-81

PDF Download

References

1. Izquierdo JL, Martìn A, de Lucas P, et al. Misdiagnosis of patients receiving inhaled therapies in primary care. Int J Chron Obstruct Pulmon Dis. 2010;5:241-249.

2. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2018. https://ginasthma.org/wp-content/uploads/2018/04/wms-GINA-2018-report-V1.3-002.pdf. Accessed January 11, 2019.

3. Aaron SD, Vandemheen KL, FitzGerald JM. Reevaluation of diagnosis in adults with physician-diagnosed asthma. JAMA. 2017; 317:269-279.

4. Spero K, Bayasi G, Beaudry L, et al. Overdiagnosis of COPD in hospitalized patients. Int J Chron Obstruct Pulmon Dis. 2017;12:2417-2423.

5. Singh H, Graber ML. Improving diagnosis in health care—the next imperative for patient safety. N Engl J Med. 2015;373:2493-2495.

6. Ball JR, Balogh E. Improving diagnosis in health care: highlights of a report from the National Academies of Sciences, Engineering, and Medicine. Ann Intern Med. 2016;164:59-61.

7. Khullar D, Jha AK, Jena AB. Reducing diagnostic errors—why now? N Engl J Med. 2015;373:2491-2493.

8. Lamprecht B, Soriano JB, Studnicka M, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148:971-985.

9. Yang CL, Simons E, Foty RG, et al. Misdiagnosis of asthma in schoolchildren. Pediatr Pulmonol. 2017;52:293-302.

10. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2019. https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf. Accessed January 12, 2019.

11. Tinkelman DG, Price DB, Nordyke RJ, et al. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma. 2006;43:75-80.

12. Abramson MJ, Schattner RL, Sulaiman ND, et al. Accuracy of asthma and COPD diagnosis in Australian general practice: a mixed methods study. Prim Care Respir J. 2012;21:167-173.

13. Sichletidis L, Chloros D, Spyratos D, et al. The validity of the diagnosis of chronic obstructive pulmonary disease in general practice. Prim Care Respir J. 2007;16:82-88.

14. Marklund B, Tunsäter A, Bengtsson C. How often is the diagnosis bronchial asthma correct? Fam Pract. 1999;16:112-116.

15. Aaron SD, Vandemheen KL, Boulet LP, et al. Overdiagnosis of asthma in obese and nonobese adults. CMAJ. 2008;179:1121-1131.

16. Aaron SD, Vandemheen KL, FitzGerald JM, et al. Reevaluation of diagnosis in adults with physician-diagnosed asthma. JAMA. 2017;317:269-279.

17. Damarla M, Celli BR, Mullerova HX, et al. Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure. Respir Care. 2006;51:1120-1124.

18. Prieto Centurion V, Huang F, Naureckus ET, et al. Confirmatory spirometry for adults hospitalized with a diagnosis of asthma or chronic obstructive pulmonary disease exacerbation. BMC Pulm Med. 2012;12:73.

19. Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155:179-191.

20. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol. 2007. 120(Suppl):S94-S138.

21. Han MK, Kim MG, Mardon R, et al. Spirometry utilization for COPD: how do we measure up? Chest. 2007;132:403-409.

22. Joo MJ, Lee TA, Weiss KB. Geographic variation of spirometry use in newly diagnosed COPD. Chest. 2008;134:38-45.

23. Thorat YT, Salvi SS, Kodgule RR. Peak flow meter with a questionnaire and mini-spirometer to help detect asthma and COPD in real-life clinical practice: a cross-sectional study. NPJ Prim Care Respir Med. 2017;27:32.

24. Kennedy DT, Chang Z, Small RE. Selection of peak flowmeters in ambulatory asthma patients: a review of the literature. Chest. 1998;114:587-592.

25. Walters JA, Hanson E, Mudge P, et al. Barriers to the use of spirometry in general practice. Aust Fam Physician. 2005;34:201-203.

26. Barr RG, Celli BR, Martinez FJ, et al. Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am J Med. 2005;118:1415.

27. Caramori G, Bettoncelli G, Tosatto R, et al. Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy. Monaldi Arch Chest Dis. 2005;63:6-12.

28. Kaminsky DA, Marcy TW, Bachand F, et al. Knowledge and use of office spirometry for the detection of chronic obstructive pulmonary disease by primary care physicians. Respir Care. 2005;50:1639-1648.

29. Foster JA, Yawn BP, Maziar A, et al. Enhancing COPD management in primary care settings. MedGenMed. 2007;9:24.

30. Bolton CE, Ionescu AA, Edwards PH, et al. Attaining a correct diagnosis of COPD in general practice. Respir Med. 2005:99:493-500.

31. Drummond MB, Dasenbrook EC, Pitz MW, et al. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA. 2008;300:2407-2416.

32. Morales DR. LABA monotherapy in asthma: an avoidable problem. Br J Gen Pract. 2013;63:627-628.

33. Nelson HS, Weiss ST, Bleecker ER, et al. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006;129:15-26.

34. van Dijk W, Tan W, Li P, et al. Clinical relevance of fixed ratio vs lower limit of normal of FEV₁/FVC in COPD: patient-reported outcomes from the CanCOLD cohort. Ann Fam Med. 2015;13:41-48.

35. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319-338.

36. Rogliani P, Ora J, Puxeddu E, et al. Airflow obstruction: is it asthma or is it COPD? Int J Chron Obstruct Pulmon Dis. 2016;11:3007-3013.

37. Global Initiative for Asthma. Diagnosis and initial treatment of asthma, COPD and asthma-COPD overlap syndrome. 2017. https://ginasthma.org/. Accessed January 12, 2019.

38. Barrecheguren M, Esquinas C, Miravitlles M. The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges. Curr Opin Pulm Med. 2015;21:74-79.

39. Kauppi P, Kupiainen H, Lindqvist A, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma. 2011;48:279-285.

40. Mannino DM, Gagnon RC, Petty TL, et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000;160:1683-1689.

41. Shaya FT, Dongyi D, Akazawa MO, et al. Burden of concomitant asthma and COPD in a Medicaid population. Chest. 2008;134:14-19.

In 2 longitudinal studies, patients with a diagnosis of asthma were recruited to undergo medication reduction and serial lung function testing. Asthma was excluded in approximately 30% of patients.^15,16 Diagnostic error has also been seen in patients hospitalized with exacerbations of COPD and asthma. One study found that only 31% of patients admitted with a diagnosis of COPD exacerbation had undergone a spirometry test prior to hospitalization.¹⁷ And of those patients with a diagnosis of COPD who underwent spirometry, 30% had results inconsistent with COPD.¹⁷

In another study, 22% of adults hospitalized for COPD or asthma exacerbations had no evidence of obstruction on spirometry at the time of hospitalization.¹⁸ This finding refutes a diagnosis of COPD and, in the midst of an exacerbation, challenges an asthma diagnosis as well. Increased awareness of clinical practice guidelines, coupled with the use and accurate interpretation of spirometry are needed for optimal management and treatment of COPD and asthma.

Airflow measurement is decisive in diagnosing COPD and asthma

Clinical practice guidelines recommend spirometry for the diagnosis of COPD and asthma and have been issued by GOLD¹⁰; the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and the European Respiratory Society¹⁹; the Global Initiative for Asthma (GINA)²; and the National Heart, Lung, and Blood Institute.²⁰

When a patient’s symptoms and risk factors suggest COPD, spirometry is needed to show persistent post-bronchodilator airflow obstruction and thereby confirm the diagnosis. However, in the United States, confirmatory spirometry is used only in about one third of patients newly diagnosed with COPD.^21,22 Similarly for asthma, in the presence of suggestive symptoms, spirometry is the preferred and most reliable and reproducible test to detect the variable expiratory airflow limitation consistent with this diagnosis.

An alternative to spirometry for the diagnosis of asthma (if needed) is a peak flow meter, a simple tool to measure peak expiratory flow. When compared with spirometry, peak flow measurements are less time consuming, less costly, and not dependent on trained staff to perform.²³However, this option does require that patients perform and document multiple measurements over several days without an objective assessment of their efforts. Unlike spirometry, the peak flow meter has no reference values or reliability and reproducibility standards, and measurements can differ from one peak flow meter to another. Thus, a peak flow meter is less reliable than spirometry for diagnosing asthma. But it can be useful for monitoring asthma control at home and in the clinic setting,²⁴ or for diagnosis if spirometry is unavailable.²³

Continue to: Barriers to the use of spirometry...